{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:42:44Z","timestamp":1784133764151,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejim.2022.11.013","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T03:15:18Z","timestamp":1668568518000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Autoimmune serology testing in clinical practice: An updated roadmap for the diagnosis of autoimmune hepatitis"],"prefix":"10.1016","volume":"108","author":[{"given":"George N.","family":"Dalekos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos K.","family":"Gatselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.11.013_bib0001","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0002","first-page":"1","article-title":"Hellenic association for the study of the liver clinical practice guidelines: autoimmune hepatitis","volume":"32","author":"Dalekos","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0003","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0004","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/liv.14480","article-title":"Incidence, prevalence and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study","volume":"40","author":"Gr\u00f8nbaek","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2022.11.013_bib0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0006","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0007","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/liv.14900","article-title":"Autoimmune hepatitis in patients aged 70 years or older: disease characteristics, treatment response and outcome","volume":"41","author":"Dalekos","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2022.11.013_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1665-2681(19)30914-7","article-title":"Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome","volume":"13","author":"Rigopoulou","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0009","doi-asserted-by":"crossref","first-page":"12662","DOI":"10.3748\/wjg.v20.i35.12662","article-title":"Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature","volume":"20","author":"Beisel","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0010","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.clinre.2018.12.002","article-title":"Autoimmune hepatitis in patients with multiple sclerosis: the role of immunomodulatory treatment","volume":"43","author":"Rigopoulou","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.02.001","article-title":"NAFLD and autoimmune hepatitis: do not judge a book by its cover","volume":"75","author":"Dalekos","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.11.013_bib0012","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2020.12.024","article-title":"Alcoholic liver disease and autoimmune hepatitis: sometimes a closer look under the surface is needed","volume":"85","author":"Rigopoulou","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.11.013_bib0013","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0014","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/his.12558","article-title":"Assessment of the histopathological key features in autoimmune hepatitis","volume":"66","author":"de Boer","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.humpath.2018.07.014","article-title":"Histologic features of autoimmune hepatitis: a critical appraisal","volume":"82","author":"Gurung","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0017","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2022.11.013_bib0018","first-page":"16334","article-title":"Recent advances in the diagnosis and management of autoimmune hepatitis","volume":"132","author":"Dalekos","year":"2022","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.ejim.2022.11.013_bib0019","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.11.013_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.30699","article-title":"Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas","volume":"35","author":"Herkel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0021","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2017.10.006","article-title":"Serology in autoimmune hepatitis: a clinical-practice approach","volume":"48","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.11.013_bib0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0023","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1365-2036.2006.03165.x","article-title":"Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C","volume":"24","author":"Gatselis","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2022.11.013_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.07.006","article-title":"Autoimmune liver disease serology in acute hepatitis E virus infection","volume":"94","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2022.11.013_bib0025","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2022.11.013_bib0026","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0027","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2022.11.013_bib0028","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.2005.027367","article-title":"Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis","volume":"59","author":"Granito","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0029","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2022.11.013_bib0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1173755","article-title":"The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation","volume":"325","author":"Palioura","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejim.2022.11.013_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 autoimmune hepatitis","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0032","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2022.11.013_bib0033","doi-asserted-by":"crossref","first-page":"e92267","DOI":"10.1371\/journal.pone.0092267","article-title":"Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejim.2022.11.013_bib0034","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2022.11.013_bib0035","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0036","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/liv.14280","article-title":"Permanent immunosuppression in SLA\/LP-positive autoimmune hepatitis is required although overall response and survival are similar","volume":"40","author":"Zachou","year":"2020","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ejim.2022.11.013_bib0037","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1016\/S0168-8278(07)62258-2","article-title":"Antibody responses specific for soluble liver antigen co-occur with Ro-52 autoantibodies in patients with autoimmune hepatitis","volume":"46","author":"Liaskos","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0038","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","article-title":"Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study","volume":"29","author":"Eyraud","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2022.11.013_bib0039","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2022.11.013_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"Van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.11.013_bib0041","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2020.01.011","article-title":"ANCA associated vasculitis","volume":"74","author":"Salvador","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2022.11.013_bib0042","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1440-1746.2000.02078.x","article-title":"Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK)","volume":"15","author":"Lindgren","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0043","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0044","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gut.34.5.658","article-title":"Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies and other autoantibodies in patients with ulcerative colitis","volume":"34","author":"Dalekos","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2022.11.013_bib0045","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/liv.13238","article-title":"Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis","volume":"37","author":"Hov","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2022.11.013_bib0046","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpeds.2019.11.028","article-title":"Seamless management of juvenile autoimmune liver disease: long-term medical and social outcome","volume":"218","author":"Di Giorgio","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejim.2022.11.013_bib0047","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2423(05)40004-9","article-title":"Autoantibodies in autoimmune liver disease","volume":"40","author":"Czaja","year":"2005","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.ejim.2022.11.013_bib0048","first-page":"561","article-title":"A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis","volume":"55","author":"Homberg","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0049","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(99)80092-0","article-title":"Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment","volume":"30","author":"Dalekos","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042737-200201000-00007","article-title":"Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece","volume":"14","author":"Dalekos","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0051","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent","volume":"54","author":"Crivelli","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0052","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0053","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0054","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","article-title":"Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques","volume":"187","author":"Muratori","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejim.2022.11.013_bib0056","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0057","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/hepr.13252","article-title":"Prompt initiation of high-dose i.v. corticosteroids seem to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis","volume":"49","author":"Zachou","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ejim.2022.11.013_bib0058","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/lt.25615","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Dalekos","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ejim.2022.11.013_bib0059","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.2196\/ijmr.9625","article-title":"Extrahepatic autoimmune diseases are prevalent in autoimmune hepatitis patients and their first-degree relatives: survey study","volume":"7","author":"Fogel","year":"2018","journal-title":"Interact J Med Res"},{"key":"10.1016\/j.ejim.2022.11.013_bib0061","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1515\/cclm-2018-0188","article-title":"International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I","volume":"56","author":"Andrade","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejim.2022.11.013_bib0062","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","author":"Czaja","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0063","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.2006.039404","article-title":"Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis","volume":"60","author":"Liaskos","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0064","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejim.2022.11.013_bib0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0066","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14737159.2016.1217159","article-title":"Molecular diagnostic testing for primary biliary cholangitis","volume":"16","author":"Gatselis","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ejim.2022.11.013_bib0067","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2022.11.013_bib0068","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2022.11.013_bib0069","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ejim.2022.11.013_bib0070","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejim.2022.11.013_bib0071","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody positive type 1-autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0072","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0073","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41584-021-00573-7","article-title":"Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis","volume":"17","author":"Granito","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0074","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0075","doi-asserted-by":"crossref","first-page":"12662","DOI":"10.3748\/wjg.v20.i35.12662","article-title":"Association of autoimmune hepatitis and systemic lupus erythematodes: A case series and review of the literature","volume":"20","author":"Beisel","year":"2014","journal-title":"World J Gastronterol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0076","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.semarthrit.2006.11.005","article-title":"How common are connective tissue disorders in patients with autoimmune hepatitis?","volume":"36","author":"Rigopoulou","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2022.11.013_bib0077","article-title":"First results from a propensity matching trial of mycophenolate mofetil vs. azathioprine in treatment-naive AIH patients","volume":"12","author":"Dalekos","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0078","article-title":"Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis","volume":"2","author":"Arvaniti","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejim.2022.11.013_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100601","article-title":"Long-term results of mycophenolate mofetil vs. azathioprine use in patients with autoimmune hepatitis","author":"Dalekos","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejim.2022.11.013_bib0080","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","article-title":"Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis","volume":"21","author":"Nezu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0081","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2022.11.013_bib0082","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0083","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1440-1746.2006.04751.x","article-title":"Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?","volume":"22","author":"Liaskos","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0084","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MEG.0000000000000870","article-title":"Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study","volume":"29","author":"Muratori","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0085","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cgh.2012.02.010","article-title":"Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis","volume":"10","author":"Dinani","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2022.11.013_bib0086","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1021\/pr500462f","article-title":"Metabolomic profiling of autoimmune hepatitis: the diagnostic utility of nuclear magnetic resonance spectroscopy","volume":"13","author":"Wang","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ejim.2022.11.013_bib0087","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.32134","article-title":"Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis","volume":"75","author":"Taubert","year":"2022","journal-title":"Hepatology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:38:38Z","timestamp":1760607518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522004034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":87,"alternative-id":["S0953620522004034"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.013","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune serology testing in clinical practice: An updated roadmap for the diagnosis of autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}